The Q4-2023 CBFO results show the company's potential to reach cash flow breakeven. Management is confident that with high variable margins from product sales, closing the remaining gap is achievable. Precipio's CEO, Ilan Danieli, is optimistic about the company's financial independence and growth potential.
$プレシピオ(PRPO.US)$I grabbed this stock after it pumped, then dipped to 2.8. I don't think it is going any lower than 2.8 again or I can always buy more. I don't want to miss out on this stock pumping though. It has been waiting to head up to the 7$ PT that analysts have for it.
Trading Tradesmanスレ主littlemissy00:
I had a 2$ average at PTPI and sold for 4.4$ already. I think that it will dip some before taking off to 5$. But I think Precipio is ready to move up to 4-5$ next. Might be better to slow enter into Precipio, while waiting for the PTPI to dip more. It's possible that PTPI is done today because it boosted all 100% gains in the first 10min of pre market. That seemed to happen to fast to be sustained all day.
プレシピオに関するコメント
NEWS
Precipio Secures a short-term $500K Credit Facility
@OBIfromMEM
$Eargo(EAR.US)$ holding enter 1.16
strong watch list
$Second Sight Medical Products(EYES.US)$
$Chembio Diagnostics(CEMI.US)$
$プレシピオ(PRPO.US)$
$36KRホールディングス(KRKR.US)$
まだコメントはありません